CellTrans’ Lantidra: Type 1 Diabetes Cell Therapy Overcame The Odds On Nontraditional Path To Approval

 
• By Sue Sutter
Drug Review Profile: Lantidra
The FDA approved Lantidra for a select population of type 1 diabetics. • Source: Pink Sheet/Shutterstock

More from Drug Review Profiles

More from Product Reviews